1. Koh, Won-Jung. . Nontuberculous Mycobacteria-Overview. In Microbiology spectrum, 5, . doi:10.1128/microbiolspec.tnmi7-0024-2016. https://pubmed.ncbi.nlm.nih.gov/28128073/
2. Fedrizzi, Tarcisio, Meehan, Conor J, Grottola, Antonella, Tortoli, Enrico, Segata, Nicola. 2017. Genomic characterization of Nontuberculous Mycobacteria. In Scientific reports, 7, 45258. doi:10.1038/srep45258. https://pubmed.ncbi.nlm.nih.gov/28345639/
3. Raman, Sunil Kumar, Siva Reddy, D V, Jain, Vikas, Misra, Amit, Singh, Amit Kumar. 2024. Mycobacteriophages: therapeutic approach for mycobacterial infections. In Drug discovery today, 29, 104049. doi:10.1016/j.drudis.2024.104049. https://pubmed.ncbi.nlm.nih.gov/38830505/
4. Daines, Cori L, Tullis, Elizabeth, Costa, Stefano, Ramsey, Bonnie, Griese, Matthias. 2023. Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study. In The European respiratory journal, 62, . doi:10.1183/13993003.02029-2022. https://pubmed.ncbi.nlm.nih.gov/37945033/
5. Zhang, Lin, Lin, Tzu-Yu, Liu, Wen-Tso, Ling, Fangqiong. 2024. Toward Characterizing Environmental Sources of Non-tuberculous Mycobacteria (NTM) at the Species Level: A Tutorial Review of NTM Phylogeny and Phylogenetic Classification. In ACS environmental Au, 4, 127-141. doi:10.1021/acsenvironau.3c00074. https://pubmed.ncbi.nlm.nih.gov/38765059/